(Q24646000)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15150570%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

title

Hormonal impact of the 17alpha-hydroxylase/C(17,20)-lyase inhibitor abiraterone acetate (CB7630) in patients with prostate cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15150570%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

0 references

1 reference

ChEBI release 2020-05-28

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15150570%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

author name string

A O'Donnell

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15150570%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

I Judson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15150570%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

M Dowsett

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15150570%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

D Dearnaley

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15150570%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

M Mason

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15150570%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

S Harland

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15150570%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

A Robbins

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15150570%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

G Halbert

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15150570%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

B Nutley

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15150570%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

M Jarman

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15150570%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

language of work or name

English

0 references

publication date

1 June 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15150570%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Cancer

28 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15150570%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

volume

90

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15150570%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15150570%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

page(s)

2317-2325

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15150570%20AND%20SRC:MED&resulttype=core&format=json

Ketoconazole blocks adrenal steroidogenesis by inhibiting cytochrome P450-dependent enzymes

28 December 2019

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409523

Secondary hormonal therapies in the treatment of prostate cancer.

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409523

A history of prostate cancer treatment

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409523

The current state of hormonal therapy for prostate cancer

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409523

Amplification and overexpression of androgen receptor gene in hormone-refractory prostate cancer

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409523

Androgen receptor stabilization in recurrent prostate cancer is associated with hypersensitivity to low androgen.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409523

Antiandrogenic effects of novel androgen synthesis inhibitors on hormone-dependent prostate cancer.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409523

Oral chemotherapy: rationale and future directions

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409523

The effects of aminoglutethimide and hydrocortisone, alone and combined, on androgen levels in post-orchiectomy prostatic cancer patients

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409523

Novel Steroidal Inhibitors of Human Cytochrome P45017.alpha.-Hydroxylase-C17,20-lyase): Potential Agents for the Treatment of Prostatic Cancer

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409523

Aminoglutethimide in advanced prostatic carcinoma.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409523

Pharmacology of novel steroidal inhibitors of cytochrome P450(17) alpha (17 alpha-hydroxylase/C17-20 lyase).

30 May 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FSJ.BJC.6601879

A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409523

Survey of gene amplifications during prostate cancer progression by high-throughout fluorescence in situ hybridization on tissue microarrays.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409523

Esters of 3-pyridylacetic acid that combine potent inhibition of 17 alpha-hydroxylase/C17,20-lyase (cytochrome P45017 alpha) with resistance to esterase hydrolysis

28 November 2018

1 reference

12 December 2020

Aminoglutethimide therapy for advanced carcinoma of the prostate

1 reference

12 December 2020

Effects of high-dose ketoconazole in patients with androgen-independent prostatic cancer

1 reference

12 December 2020

Overview of phase III trials on combined androgen treatment in patients with metastatic prostate cancer

1 reference

12 December 2020

Biochemistry and pharmacokinetics of potent non-steroidal cytochrome P450(17alpha) inhibitors

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.BJC.6601879

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15150570%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

28 December 2019

1037763577

0 references

1197242

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

2 references

1197242

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15150570%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

PubMed publication ID

15150570

2 references

Consolidated OpenCitations Corpus – April 2017

1197242